153 related articles for article (PubMed ID: 8251378)
1. Reversibility of thrombin-induced decrease in platelet glycoprotein Ib function.
Lu H; Menashi S; Garcia I; Cramer EM; Li H; Tenza D; De Romeuf C; Soria J; Soria C
Br J Haematol; 1993 Sep; 85(1):116-23. PubMed ID: 8251378
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.
Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT
Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727
[TBL] [Abstract][Full Text] [Related]
3. Reversible translocation of glycoprotein Ib in plasmin-treated platelets: consequences for platelet function.
Lu H; Soria C; Soria J; De Romeuf C; Perrot JY; Tenza D; Garcia I; Caen JP; Cramer EM
Eur J Clin Invest; 1993 Dec; 23(12):785-93. PubMed ID: 7511534
[TBL] [Abstract][Full Text] [Related]
4. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib.
George JN; Torres MM
Blood; 1988 May; 71(5):1253-9. PubMed ID: 3258766
[TBL] [Abstract][Full Text] [Related]
5. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
6. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.
Soslau G; Class R; Morgan DA; Foster C; Lord ST; Marchese P; Ruggeri ZM
J Biol Chem; 2001 Jun; 276(24):21173-83. PubMed ID: 11283012
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination.
Tanoue K; Jung SM; Yamamoto N; Yamazaki H
Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731
[TBL] [Abstract][Full Text] [Related]
8. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex.
Berndt MC; Du XP; Booth WJ
Biochemistry; 1988 Jan; 27(2):633-40. PubMed ID: 2450575
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
[TBL] [Abstract][Full Text] [Related]
10. Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size.
Federici AB; Bader R; Pagani S; Colibretti ML; De Marco L; Mannucci PM
Br J Haematol; 1989 Sep; 73(1):93-9. PubMed ID: 2803984
[TBL] [Abstract][Full Text] [Related]
11. Recombinant fragment of von Willebrand factor AR545C inhibits platelet binding to thrombin and platelet adhesion to thrombin-treated endothelial cells.
Dardik R; Varon D; Eskaraev R; Tamarin I; Inbal A
Br J Haematol; 2000 Jun; 109(3):512-8. PubMed ID: 10886196
[TBL] [Abstract][Full Text] [Related]
12. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
14. Effects of leukocyte-derived cathepsin G on platelet membrane glycoprotein Ib-IX and IIb-IIIa complexes: a comparison with thrombin.
Molino M; Di Lallo M; Martelli N; de Gaetano G; Cerletti C
Blood; 1993 Oct; 82(8):2442-51. PubMed ID: 8400294
[TBL] [Abstract][Full Text] [Related]
15. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible.
Michelson AD; Benoit SE; Kroll MH; Li JM; Rohrer MJ; Kestin AS; Barnard MR
Blood; 1994 Jun; 83(12):3562-73. PubMed ID: 8204882
[TBL] [Abstract][Full Text] [Related]
16. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
Chang MC; Lin HK; Peng HC; Huang TF
Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223
[TBL] [Abstract][Full Text] [Related]
18. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane.
Berndt MC; Gregory C; Kabral A; Zola H; Fournier D; Castaldi PA
Eur J Biochem; 1985 Sep; 151(3):637-49. PubMed ID: 3161731
[TBL] [Abstract][Full Text] [Related]
19. Comparison of thrombin and ristocetin in the interaction between von Willebrand factor and platelets.
Harrison RL; McKee PA
Blood; 1983 Aug; 62(2):346-53. PubMed ID: 6307433
[TBL] [Abstract][Full Text] [Related]
20. Prelabeled glycoprotein Ib/IX receptors are not cleared from exposed surfaces of thrombin-activated platelets.
White JG; Krumwiede MD; Cocking-Johnson D; Escolar G
Am J Pathol; 1996 Aug; 149(2):629-38. PubMed ID: 8702001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
